BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21406083)

  • 1. The clinical significance of the FUS-CREB3L2 translocation in low-grade fibromyxoid sarcoma.
    Rose B; Tamvakopoulos GS; Dulay K; Pollock R; Skinner J; Briggs T; Cannon S
    J Orthop Surg Res; 2011 Mar; 6():15. PubMed ID: 21406083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
    Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM
    Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
    Panagopoulos I; Storlazzi CT; Fletcher CD; Fletcher JA; Nascimento A; Domanski HA; Wejde J; Brosjö O; Rydholm A; Isaksson M; Mandahl N; Mertens F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):218-28. PubMed ID: 15139001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma.
    Bartuma H; Möller E; Collin A; Domanski HA; Von Steyern FV; Mandahl N; Mertens F
    Cancer Genet Cytogenet; 2010 Jun; 199(2):143-6. PubMed ID: 20471519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.
    Mertens F; Fletcher CD; Antonescu CR; Coindre JM; Colecchia M; Domanski HA; Downs-Kelly E; Fisher C; Goldblum JR; Guillou L; Reid R; Rosai J; Sciot R; Mandahl N; Panagopoulos I
    Lab Invest; 2005 Mar; 85(3):408-15. PubMed ID: 15640831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
    Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
    Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
    Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
    Matsuyama A; Hisaoka M; Shimajiri S; Hayashi T; Imamura T; Ishida T; Fukunaga M; Fukuhara T; Minato H; Nakajima T; Yonezawa S; Kuroda M; Yamasaki F; Toyoshima S; Hashimoto H
    Am J Surg Pathol; 2006 Sep; 30(9):1077-84. PubMed ID: 16931951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-based polymerase chain reaction for detecting FUS-CREB3L2 in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
    Matsuyama A; Hisaoka M; Shimajiri S; Hashimoto H
    Diagn Mol Pathol; 2008 Dec; 17(4):237-40. PubMed ID: 18382348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma.
    Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Sei A; Sugaya J; Iwata S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2021 Nov; 34(6):1919-1928. PubMed ID: 34535876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade fibromyxoid sarcoma of the extremities: a clinicopathologic study of 24 cases and review of the literature.
    Sambri A; Righi A; Tuzzato G; Donati D; Bianchi G
    Pol J Pathol; 2018; 69(3):219-225. PubMed ID: 30509048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool.
    Patel RM; Downs-Kelly E; Dandekar MN; Fanburg-Smith JC; Billings SD; Tubbs RR; Goldblum JR
    Am J Dermatopathol; 2011 Apr; 33(2):140-3. PubMed ID: 21399449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
    Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
    Mohamed M; Fisher C; Thway K
    Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deeply located low-grade fibromyxoid sarcoma with FUS-CREB3L2 gene fusion in a 5-year-old boy with review of literature.
    Kurisaki-Arakawa A; Suehara Y; Arakawa A; Takagi T; Takahashi M; Mitani K; Kaneko K; Yao T; Saito T
    Diagn Pathol; 2014 Sep; 9():163. PubMed ID: 25183312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerosing epithelioid fibrosarcoma - a report of two cases with cytogenetic analysis of FUS gene rearrangement by FISH technique.
    Rekhi B; Folpe AL; Deshmukh M; Jambhekar NA
    Pathol Oncol Res; 2011 Mar; 17(1):145-8. PubMed ID: 20499220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FUS-CREB3L2/L1-positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1.
    Möller E; Hornick JL; Magnusson L; Veerla S; Domanski HA; Mertens F
    Clin Cancer Res; 2011 May; 17(9):2646-56. PubMed ID: 21536545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.
    Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR
    Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization.
    Thway K; Ng W; Benson C; Chapman J; Fisher C
    Int J Surg Pathol; 2015 Sep; 23(6):454-60. PubMed ID: 26135531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular low-grade fibromyxoid sarcoma: a case report.
    Liao KS; Huang WT; Yang SF; Chien SH; Hsieh TJ; Chai CY; Wu CC
    Kaohsiung J Med Sci; 2009 Aug; 25(8):448-54. PubMed ID: 19605340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.